Obesity; Glp-1; Metabolic Health; Weight Loss

  1. madman

    Survodutide in Obesity: 25% REDUCTION IN SUBCUTANEOUS FAT, 34% REDUCTION IN VISCERAL FAT and 63% REDUCTION IN LIVER FAT

    Truly impressive! * the really exciting data of SYNCHRONIZE-1 was not the weight loss it was actually the metabolic health gains so we see that there was an improvement in glycemia and blood pressure but there was a. 63% REDUCTION IN FAT IN THE LIVER so imagine you had 16% weight loss but 25%...

Obesity; Glp-1; Metabolic Health; Weight Loss

Obesity; Glp-1; Metabolic Health; Weight Loss

Beyond Testosterone Podcast

Back
Top